β¨ Medicine Distribution Consents
17 SEPTEMBER NEW ZEALAND GAZETTE 3589
Schedule
| Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name (if any) |
|---|---|---|---|
| Ammonium chloride 25 mg/mL, diphenhydramine hydrochloride 2.5 mg/mL | Syrup | PSM Holdings Limited, Wiri, Auckland | Diphenacough |
| Bisacodyl 10 mg | Suppository | C B Fleet & Co Inc., Lynchburg, Virginia, United States of America | Fleet Laxative Suppositories |
| Metoclopramide hydrochloride 5 mg/mL | Injection, solution (syringe and polyamp) | Astra Pharmaceuticals Pty Limited, North Ryde, New South Wales, Australia | Metoclopramide |
| Ketoconazole 2% w/w | Shampoo | Douglas Pharmaceuticals Limited, Mount Wellington, Auckland | Sebizole |
| Basiliximab 20 mg Diluent: Water for injection |
Injection, powder with diluent | Novartis Pharma AG., Basel, Switzerland Diluent: Novartis Pharma AG., Stein, Switzerland |
Simulect |
| Cefaclor monohydrate 27.8 mg/mL, 55.6 mg/mL equivalent to 25 mg/mL, 50 mg/mL cefaclor anhydrous | Suspension, oral | Ranbaxy Laboratories Limited, Dewas, Madhya Pradesh, India | Locef |
| Cefaclor monohydrate 267.5 mg/mL, 535 mg equivalent to 250 mg, 500 mg cefaclor anhydrous | Capsules, powder filled | Ranbaxy Laboratories Limited, Dewas, Madhya Pradesh, India | Locef |
Dated this 8th day of September 1998.
G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.
g06558
Provisional Consent to the Distribution of a New Medicine
Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
| Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name (if any) |
|---|---|---|---|
| Lamivudine 5 mg/mL | Solution, oral | Glaxo Wellcome Operations, Speke, Liverpool, United Kingdom | Zeffix |
Note: This consent is valid for 2 years from the date of publication of this notice.
Dated this 14th day of September 1998.
G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.
g06685
Consent to the Distribution of a Changed Medicine
Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the changed medicine which was referred to the Minister of Health under the provisions of section 24 (5) of the Act and is set out in the Schedule hereto:
Schedule
| Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name (if any) |
|---|---|---|---|
| Lamivudine 100 mg | Tablet, film coated | Glaxo Wellcome Operations, Ware, Hertfordshire, United Kingdom | Zeffix |
Note: This consent is valid for 2 years from the date of publication of this notice.
Dated this 14th day of September 1998.
G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.
g06686
Next Page →
PDF embedding disabled (Crown copyright)
View this page online at:
VUW Te Waharoa —
NZ Gazette 1998, No 148
NZLII —
NZ Gazette 1998, No 148
β¨ LLM interpretation of page content
π₯ Consent to the Distribution of a New Medicine
π₯ Health & Social Welfare8 September 1998
Medicines Act 1981, New Medicine, Distribution
- G. R. Boyd, Chief Advisor, Regulation and Safety
π₯ Provisional Consent to the Distribution of a New Medicine
π₯ Health & Social Welfare14 September 1998
Medicines Act 1981, New Medicine, Provisional Consent, Distribution
- G. R. Boyd, Chief Advisor, Regulation and Safety
π₯ Consent to the Distribution of a Changed Medicine
π₯ Health & Social Welfare14 September 1998
Medicines Act 1981, Changed Medicine, Distribution
- G. R. Boyd, Chief Advisor, Regulation and Safety